Filing Flows

Filing Flows › BioAge Labs (BIOA) › Next earnings date

BioAge Labs (BIOA) earnings: missed the estimate

BioAge Labs (BIOA) reported on Nov 5, 2026 and missed the EPS estimate: −$0.73 against −$0.63 (-16.6%). Revenue was $298K for Q3 2026, -86% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result−16.6% vs estimate
Beat rate40%

The last report

BioAge Labs reported revenue of $298K for the third quarter 2026 (-86% Y/Y), net loss $33.5M. How it makes money → · Every quarter →

BioAge Labs: EPS against the estimate, last 5 reportsBioAge Labs: EPS against the estimate, last 5 reportsEstimateReported−$0.51−$0.56Nov 25−$0.67−$0.72Mar 26−$0.63−$0.52May 26−$0.62−$0.58Aug 26−$0.63−$0.73Nov 26
Latest (Nov 26): Estimate −$0.63, Reported −$0.73.

BioAge Labs' latest quarter

BioAge Labs, Q3 2026: revenue $298K (-86% year over year), net loss $33.5M, operating cash flow −$31.0M. The chart follows the revenue to costs, profit and cash.

Questions

Did BioAge Labs beat earnings?

BioAge Labs (BIOA) reported on Nov 5, 2026 and missed the EPS estimate: −$0.73 against −$0.63 (-16.6%).

When does BIOA report earnings?

The next date is not set yet.

Does BioAge Labs usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.